TKT and acute myeloid leukemia: In AML, the FLT3 receptor, which is usually present on HSPC, is frequently overexpressed and mutated at diagnosis through an internal tandem duplication (25%, ITD) or point mutation in the TK domain (7%–10%, TKD) (Figure 1).